Found: 12
Select item for more details and to access through your institution.
Receptor kinase profiles identify a rationale for multitarget kinase inhibition in immature T-ALL.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 2, p. 305, doi. 10.1038/leu.2012.177
- By:
- Publication type:
- Article
EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols.
- Published in:
- 2012
- By:
- Publication type:
- journal article
EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols.
- Published in:
- Leukemia (08876924), 2012, v. 26, n. 9, p. 1986, doi. 10.1038/leu.2012.122
- By:
- Publication type:
- Article
EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes.
- Published in:
- Leukemia (08876924), 2012, v. 26, n. 9, p. 1908, doi. 10.1038/leu.2012.120
- By:
- Publication type:
- Article
Most immature T-ALLs express Ra-IL3 (CD123): possible target for DT-IL3 therapy.
- Published in:
- 2006
- By:
- Publication type:
- Letter
Brigatinib in patients with ALK‐positive anaplastic large cell lymphoma who have failed brentuximab vedotin.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 505, doi. 10.1002/hon.3164_373
- By:
- Publication type:
- Article
MEMBRANE EXPRESSION OF NK RECEPTOR KIR3DL2 CONTRIBUTES TO DELINEATE THE ACUTE‐TYPE AND IS A THERAPEUTIC TARGET IN ADULT T‐CELL LEUKEMIA/LYMPHOMA.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 271, doi. 10.1002/hon.82_2630
- By:
- Publication type:
- Article
KIR3DL2 IS EXPRESSED IN PERIPHERAL T‐CELL LYMPHOMAS AND MAY BE A THERAPEUTIC TARGET.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 204, doi. 10.1002/hon.21_2630
- By:
- Publication type:
- Article
MEMBRANE EXPRESSION OF NK RECEPTOR KIR3DL2 CONTRIBUTES TO DELINEATE THE ACUTE‐TYPE AND IS A THERAPEUTIC TARGET IN ADULT T‐CELL LEUKEMIA/LYMPHOMA.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 271, doi. 10.1002/hon.82_2630
- By:
- Publication type:
- Article
KIR3DL2 IS EXPRESSED IN PERIPHERAL T‐CELL LYMPHOMAS AND MAY BE A THERAPEUTIC TARGET.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 204, doi. 10.1002/hon.21_2630
- By:
- Publication type:
- Article
NKP46 EXPRESSION IS A DIAGNOSTIC AND PROGNOSTIC BIOMARKER IN PRIMARY GASTROINTESTINAL T-CELL LYMPHOPROLIFERATIONS. A CELAC NETWORK STUDY.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 44, doi. 10.1002/hon.2437_26
- By:
- Publication type:
- Article
Absence of circulating mast cell precursors in paediatric mastocytosis: could it reflect a different pathophysiology between adults and children with mastocytosis?
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2014, v. 28, n. 7, p. 967, doi. 10.1111/jdv.12182
- By:
- Publication type:
- Article